|

IBI343,Gemcitabine, Albumin-bound Paclitaxel Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Innovent Biologics (Suzhou) Co. Ltd.1

Indications

  • CLDN18.2 Positive1
  • Gastric/Gastroesophageal Junction Adenocarcinoma1
  • Pancreatic Ductal Adenocarcinoma1
  • Cancer1

Other1 trial

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.